This test is most useful if any of these apply to you.
Your nervous system runs on a balance between 'go' and 'stop' signals. GABA (gamma-aminobutyric acid) is the body's most abundant 'stop' signal, and measuring it in your blood offers a newer window into mood, sleep biology, and how your body handles stress and aging.
This is an exploratory test, not a standard clinical panel. There are no agreed-upon reference ranges, and a single reading will not diagnose anything. Treated as one data point in a broader picture, though, it can complement markers of stress, inflammation, and aging that most people never check.
The lab measures the concentration of GABA circulating in your blood. Most GABA in your body is made and used inside the brain, where it calms nerve cell activity. A smaller fraction is produced by pancreatic cells, immune cells, and gut bacteria, and some of that reaches your bloodstream. Blood GABA is a related but separate measurement from brain GABA, and the two do not always move together.
Because of this, blood GABA is best thought of as a systemic snapshot of the molecule. It reflects production, breakdown, and transport across many tissues, not specifically what is happening inside your brain at any given moment.
Research has linked low GABA activity to depression. One study of 106 adults with depression found that those with a history of suicidal behavior had significantly lower serum GABA than those without, and lower levels tracked with worse depression scores, lower levels of a brain-growth protein called BDNF (brain-derived neurotrophic factor), and higher cortisol.
Studies of brain GABA using a specialized scan called magnetic resonance spectroscopy (a related but different measurement, taken from brain tissue rather than blood) also tend to show lower GABA in people with major depression. Whether blood GABA fully mirrors this brain pattern is still being worked out, so blood results should not be used to diagnose or rule out depression on their own.
In a study of 120 healthy adults, serum GABA and a related ratio (GABA compared with alpha-aminobutyric acid, another small amino acid) rose with age and were linked to worse physical performance. In other words, older adults with worse mobility tended to carry higher circulating GABA than younger, more active people. This association held independently of body weight and routine metabolic markers.
Separate work in older women found that those with osteoporotic fractures had lower serum GABA than unaffected peers, and GABA tracked with bone mineral density and activity level. The two findings point in opposite directions in different populations, which is part of why this marker is still considered research-grade rather than a decision tool.
Blood GABA shifts sharply during serious illness. Hospitalized adults with severe COVID-19 showed markedly reduced plasma GABA, and a level below 0.214 micromoles per liter (a unit for very small blood concentrations) separated cases from healthy people with high accuracy. The authors proposed GABA as one potential signal of metabolic disturbance in severe infection.
In a prospective study of 3,486 adults who had just had an ischemic stroke (a stroke caused by blocked blood flow), higher plasma GABA and several related amino acids were linked to worse recovery outcomes. This is a counterintuitive finding because GABA is often framed as protective. The simplest interpretation is that acute illness releases more GABA into circulation, and higher blood levels in this setting mark a sicker physiology rather than better brain protection.
This apparent contradiction matters when you read your own number. Blood GABA is not a simple 'higher is better' or 'lower is better' marker. Different clinical contexts carry different meanings, which is why this test works best as part of a broader panel and tracked over time rather than interpreted in isolation.
Blood GABA has no universally standardized clinical cutpoints. Published values come from small research cohorts using different lab techniques, and results are not directly comparable between labs. The ranges below are illustrative orientation from research reports, not clinical targets.
| Assay and Sample Type | Reported Value in Healthy Adults | Source |
|---|---|---|
| Plasma, liquid chromatography mass spectrometry | About 99 nanograms per milliliter, give or take 34 | Song et al., J Chromatography B, 2005 (n=12) |
| Plasma, radioreceptor assay | About 309 picomoles per milliliter, give or take 79 | Schmidt and Löscher, J Neurol Neurosurg Psychiatry, 1982 (n=49) |
| Serum, healthy older adults | Rises with age and may be higher in people with worse mobility | Lyssikatos et al., Scientific Reports, 2023 (n=120) |
Compare your result to prior values from the same lab, using the same method. That is the most meaningful reading you can get from this test today.
Because blood GABA has no official threshold, the real value of this test comes from tracking it over time in the same lab. A baseline tells you where you are starting. A repeat in three to six months, especially if you are making changes to sleep, stress management, or supplementation, shows whether the trend is moving. At least annual monitoring makes sense if you want to follow this marker as part of a broader longevity profile.
Always draw the sample under similar conditions: same time of day, fasting status, and without taking a GABA supplement in the hours beforehand. Otherwise the trend you see may reflect testing conditions rather than biology.
A single out-of-typical-range result is not a diagnosis. It is a prompt to look wider. If your value is unusually low or high, consider retesting in four to six weeks under consistent conditions to rule out a transient cause. A result that persists alongside symptoms of depression, anxiety, sleep disruption, or unexplained fatigue is worth discussing with a psychiatrist or integrative physician, particularly if other markers like cortisol, homocysteine, or inflammatory signals are also abnormal.
If you have suspected autoimmune brain symptoms such as new seizures, rapid personality changes, or encephalopathy, blood GABA is not the right test. The relevant test in that context is GABA-B receptor antibodies, a separate assay that looks for immune attack on the GABA system and requires neurological workup.
Evidence-backed interventions that affect your GABA level
Gamma-Aminobutyric Acid is best interpreted alongside these tests.
Gamma-Aminobutyric Acid is included in these pre-built panels.